Pfizer Inc.

Recent Events

News & Analysis

finance and pfizer inc. - All News and Analysis

• Why Pfizer's Deal with Protalix Is Bad News for Big Pharma Sales Reps

  BNET - 2009-12-01

  Pfizer's partnership with Protalix BioTherapeutics for Gaucher's disease drug Uplyso taliglucerase alfa offers one more piece of evidence that the days of traditional big pharma sales reps are limited. by Trista Morrison

  Tags: Pfizer Inc., Pharmaceutical Company, Business Structures, Finance, Trista Morrison

• J&J CEO Rubs Pfizer's Face in Disastrous Consumer Products Sale of '06

  BNET - 2009-11-25

  Toldya: One year ago, BNET noted that Pfizer PFE must have been crazy to sell its consumer products unit to Johnson & Johnson JNJ. The deal included brands such as Nicorette, Zantac and Benadryl. J&J's Q3 earnings report showed that the consumer products unit has done much better than its...

  Tags: Johnson & Johnson, Pfizer Inc., Sales Strategy, Healthcare, Branding, Financial Accounting, Sales, Marketing, Finance, Jim Edwards

• Pfizer Got $160M in Tax Money to Build in Connecticut

  BNET - 2009-11-23

  Want Pfizer PFE to build a new plant in your town? That could be an expensive date, according to a McClatchy-Tribune News service report. It cost Connecticut taxpayers $160 million to host the world's largest drug company between 2000 and 2011: by Jim Edwards

  Tags: Pfizer Inc., Connecticut, Taxes, Free Trade, Personal Finance, Financial Planning, Finance, Jim Edwards

• Pfizer Scientist Stabbed Wife After Job Loss, Police Say

  BNET - 2009-11-18

  A former Pfizer PFE employee who lost his job and “was convinced he could not provide for his family any further,” has been charged with stabbing his wife, according to police. Pfizer is in the process of laying off 19,500 employees in its merger with Wyeth. Asbill was involved in...

  Tags: Job, Pfizer Inc., Job Loss, Recruitment & Selection, Mergers & Acquisitions, Human Resources, Workforce Management, Investment, Finance, Jim Edwards

• As Tax Breaks for Pfizer End, Jobs Disappear

  BNET - 2009-11-16

  As Pfizer PFE reorganizes after its merger with Wyeth, municipalities are finding that the tax deals they once struck to keep the drug giant in town are having short-term advantages at best and, at worst, no effect at all. Pfizer must make 19,500 layoffs across its empire to make the...

  Tags: Job, Merger, Pfizer Inc., Tax Break, Mergers & Acquisitions, Taxes, Free Trade, Personal Finance, Investment, Finance, Financial Planning, Jim Edwards

• Pfizer's R&D Cuts Render Kelo v. New London Eminent Domain Case a Waste of Time

  BNET - 2009-11-10

  Pfizer PFE will close its New London, Conn., site and consolidate operations there at the nearby Groton, Conn., site in a swathe of R&D closures as the company seeks 19,500 job cuts in the wake of its merger with Wyeth. Pfizer's abandonment of its plans for New London render moot...

  Tags: R&D, Pfizer Inc., Connecticut, Research & Development, Mergers & Acquisitions, Business Operations, Investment, Finance, Jim Edwards

• Pfizer Aiming for 30,900 Layoffs Through 2012

  BNET - 2009-11-06

  Pfizer has laid off 26,300 employees since 2005, and hopes eventually to lay off a total of 30,900 through 2012, according to its 10-Q filing with the SEC. The company had several rounds of layoffs before its acquisition of Wyeth in an attempt to get $6 billion in annual savings...

  Tags: Wyeth, Layoff, Pfizer Inc., Workforce Management, Mergers & Acquisitions, Human Resources, Investment, Finance, Jim Edwards

• Pfizer Unveils Shiny New "Leaping" Logo

  BNET - 2009-11-05

  Pfizer PFE, fresh from consummating its merger with Wyeth WYE, has unveiled a new logo. Don't get too excited -- it looks a lot like the old logo. by Jim Edwards

  Tags: Logo, Pfizer Inc., Mergers & Acquisitions, Investment, Finance, Jim Edwards

• Pfizer Produces Snapshot of Combined Company: $66B in Revenue; Only $2.2B in Cash

  BNET - 2009-10-23

  Pfizer has produced the first snapshot of what the combined Pfizer-Wyeth company looks like in the form of a pro forma set of financial statements that melds both companies' numbers through the end of June 2009. No surprise: It's massive. by Jim Edwards

  Tags: Revenue, Pfizer Inc., Financial Statements, Financial Planning, Financial Accounting, Operational Accounting, Finance, Jim Edwards

• Pfizer Q3: Healthy Profit Masks Revenue Decline

  BNET - 2009-10-20

  This merger with Wyeth can't come soon enough for Pfizer. The company's revenues were down 3 percent to $11.6 billion in Q3 2009, although net income was $2.8 billion up 26 percent. That healthy profit growth masks the reality of Pfizer's business: Of all its drugs, only four saw growth....

  Tags: Revenue, Pfizer Inc., Operational Accounting, Mergers & Acquisitions, Finance, Investment, Jim Edwards